期刊文献+

还原型谷胱甘肽对胰腺炎相关性腹腔积液诱导的大鼠肝损伤的疗效及其机制 被引量:2

Effect and mechanism of reduced glutathione on liver injury induced by pancreatitis-associated ascitic fluid in rats
下载PDF
导出
摘要 目的建立大鼠经腹腔内注射胰腺炎相关性腹腔积液(PAAF)诱导的急性肝损伤模型并研究还原型谷胱甘肽(GSH)对该损伤的疗效及机制。方法先制备急性出血坏死性胰腺炎模型(AHNP)并收集PAAF。A组(对照组)腹腔内注射生理盐水,B组(模型组)腹腔内注射PAAF,C组(GSH治疗组)在向腹腔内注射PAAF前1 h于尾静脉注射GSH。腹腔注射后6 h、12 h分批处死大鼠,每时间点8只。测定大鼠ALT、AST、血清淀粉酶(AmYL)浓度,TBA法检测肝组织丙二醛(MDA)含量,ELISA法检测血清肿瘤坏死因子(TNF-α)、白细胞介素(IL-6),苏木精-伊红染色后光镜观察胰腺及肝损伤情况。结果B组血清ALT、AST、AmYL较同时间段A组升高(P<0.05),血清TNF-α、IL-6浓度及肝组织MDA含量明显升高(P<0.05),B组肝细胞水肿、炎性细胞浸润;C组与同时间段B组相比上述各指标均有降低(P<0.05),肝病理损害较轻。结论GSH通过抗氧自由基、炎症递质的作用减轻PAAF诱导的肝损伤。 Objective To investigate the therapeutic effect of reduced glutathione (GSH) on acute liver injury induced by peritoneal injection of PAAF by establishing the animal injury model in rats and to explore the possible mechanisms underlying the injury and protection. Methods 40 rats were prepared to establish AHNP models. Another 48 rats were randomized into 3 groups ( n = 16) : group A served as the normal control, with 8 ml normal saline (NS) injected into the peritoneal cavity of the rats; group B as the model control with 8 ml PAAF injected intraperifoneally; group C as the treatment group, with GSH at the dose of 400 mg/kg administrated into the caudal vein 1 h before PAAF injection. At 6 h and 12 h after intraperitoneal injection, the rats were sacrificed in two batches, with 8 rats per batch. The concentration of ALT, AST, AMYL and MDA were measured. Histopathological examination of the liver and pancreas samples were examined with hematoxylin and eosin stain. The levels of IL - 6 and TNF - α in serum were detected by ELISA. Results The levels of ALT, AST, TNF - α were higher than those in group A at during the same period ( P 〈 0. 05 ) , while IL - 6 in the serum and MDA in liver tissue in group B were significantly higher than those in group A ( P 〈 0.05 ). There was edema in liver cells in group B, with infusion of inflammatory cells. The parameters mentioned above were simultaneously lower in group B compared with those in group C, suggesting the pathological injurywas reduced after GSH administration. Conclusions The animal models of acute liver injury induced by PAAF were successfully established and GSH can reduce the PAAF - induced acute liver injury by resisting the effects of oxygen free radicals and inflammatory mediators.
出处 《徐州医学院学报》 CAS 2009年第6期388-390,共3页 Acta Academiae Medicinae Xuzhou
关键词 胰腺炎相关性腹腔积液 还原型谷胱甘肽 肝损伤 pancreatitis - associated ascitic fluid reduced glutathione liver injury
  • 相关文献

参考文献5

二级参考文献28

  • 1张莉芸,黄烽,张江林,赵华,刘湘源,朱剑,赵伟,邓小虎,邹艳红.Infliximab治疗强直性脊柱炎发生皮肤不良反应七例临床分析[J].中华风湿病学杂志,2005,9(3):166-168. 被引量:9
  • 2Siegel SA, Shealy DJ, Nakada MT, et al. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenie mice from cachexia and TNF lethality in vivo [ J ]. Cytokine,1995,7( 1 ) : 15-25.
  • 3Derkx B, Taminiau J, Radema S, et al. Tumour-necrosis-factor antibody treatment in Crohn's disease[ J]. Lancet, 1993,342 (8864) : 173-174.
  • 4Hyams JS, Markowitz J, Wyllie R. Use of infliximab in the treatment of Crohn's disease in children and adolescents[J]. J Pediatr, 2000, 137(2) :192-196.
  • 5Targan SR, Hanauer SB, vail Deventer S, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease[J]. N Engl J Med, 1997,337(15) : 1029-1035.
  • 6Farrell RJ, Lodhavia PI, Alsahli M, et al. Infliximab therapy in 100 Crohn's disease patients: adverse events and clinical efficacy [ J ]. Gastroenterology,2000, 118[Suppl 2] :A5664.
  • 7Cohen RD. Infliximab as first-line therapy for severe Crohn's disease ?[ J]. Inflamm Bowel Dis, 2002.8( 1 ) : 58-59.
  • 8Greenberg GR. Infliximab as first-line therapy for Crohn's disease is premature [ J ]. Inflamm Bowel Dis, 2002,8 ( 1 ) : 60-62.
  • 9Oruc N, Ozutemiz AO, Yukselen V, et al. Infliximab : a new therapeutic agent in acute pancreatitis? [ J ]. Pancreas, 2004,28 ( 1 ) : e1-e8.
  • 10Chey WY. Infliximab for patients with refractory ulcerative colitis[ J ].Inflamm Bowel Dis, 2001,7 [ Supp 11 ] : S30-33.

共引文献24

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部